Skip to main content
Equibles

SUSQUEHANNA INTERNATIONAL GROUP, LLP

Position in MESO — Mesoblast Ltd

CIK 1446194 BALA CYNWYD, PA
Back to MESO Full portfolio

Position in MESO

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$6,193,276
+$249,337 QoQ
Shares Held
457,744
+18.4% QoQ
Ownership
0.353%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#3
of 72 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in MESO Over Time

Shares Held

Position Value (USD)

Derivatives in MESO

reported options exposure · as of Jun 30, 2026
CallValue
$5,384,940
CallShares
398,000
PutValue
$1,815,726
PutShares
134,200

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $1,653,301,875 across 349 Biotechnology names. MESO ranks #38 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ABVX
Abivax S.A.
 1,053,896 $140,442,180
2 CYTK
Cytokinetics Inc
 1,549,458 $131,998,327
3 REGN
Regeneron Pharmaceuticals, Inc.
 180,219 $112,373,755
4 ALNY
Alnylam Pharmaceuticals, Inc.
 294,460 $88,641,293
5 MDGL
Madrigal Pharmaceuticals, Inc.
 148,610 $79,796,139
6 INSM
INSMED Inc
 729,354 $77,763,723
7 VRTX
Vertex Pharmaceuticals Inc / Ma
 144,174 $71,615,550
8 AGIO
Agios Pharmaceuticals, Inc.
 1,375,558 $51,046,957

All Filings in MESO

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $5,384,940 398,000
2026-06-30 $6,193,276 457,744
2026-06-30 $1,815,726 134,200
2026-03-31 $3,497,412 227,400
2026-03-31 $1,548,766 100,700
2026-03-31 $5,943,939 386,472
2025-12-31 $9,716,344 538,600
2025-12-31 $1,899,612 105,300
2025-12-31 $7,754,385 429,844
2025-09-30 $3,545,811 220,100
2025-09-30 $4,373,671 271,488
2025-09-30 $1,245,303 77,300
2025-06-30 $1,237,104 113,600
2025-06-30 $2,554,652 234,587
2025-06-30 $1,720,620 158,000
2025-03-31 $3,256,543 260,941
2025-03-31 $1,213,056 97,200
2025-03-31 $3,005,184 240,800
2024-12-31 $5,199,480 262,600
2024-12-31 $3,048,784 153,979
2024-12-31 $2,942,280 148,600
2024-09-30 $953,782 116,742
2024-09-30 $276,146 33,800
2024-09-30 $1,545,764 189,200
2024-06-30 $1,020,138 149,800
2024-06-30 $494,998 72,687
2024-06-30 $435,840 64,000
2024-03-31 $461,922 92,200
2024-03-31 $133,266 26,600
2024-03-31 $288,105 57,506
2023-12-31 $73,040 66,400
2023-12-31 $288,090 261,900
2023-12-31 $248,739 226,127
2023-09-30 $135,423 110,100
2023-09-30 $113,670 92,415
2023-09-30 $154,488 125,600
2023-06-30 $128,248 32,800
2023-06-30 $309,351 79,118
2023-03-31 $172,817 52,528
2022-12-31 $258,990 89,000
2022-12-31 $401,638 138,020
2022-12-31 $53,544 18,400
2022-09-30 $46,410 18,200
2022-09-30 $367,455 144,100
2022-09-30 $536,861 210,534
2022-06-30 $230,309 103,743
2022-06-30 $45,954 20,700
2022-06-30 $374,514 168,700
2022-03-31 $236,320 56,000
2022-03-31 $886,200 210,000